| 产品描述: | CCMI (AVL-3288) is a potent and selective α7 nAChR-positive allosteric modulator, does not bind to or activate α7 nAChRs via the orthosteric site, and causes significant positive modulation of agonist-induced currents at α7 nAChRs. CCMI has potential in CNS diseases with cognitive dysfunction |
| 靶点: |
α7 nAChR |
| 参考文献: |
1. Ng HJ, et al. Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators. Proc Natl Acad Sci U S A. 2007 May 8;104(19):8059-64. Epub 2007 Apr 30. |
| 溶解性: |
DMSO : 100 mg/mL (257.57 mM; Need ultrasonic) |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.576 ml |
12.878 ml |
25.757 ml |
| 5 mM |
0.515 ml |
2.576 ml |
5.151 ml |
| 10 mM |
0.258 ml |
1.288 ml |
2.576 ml |
| 50 mM |
0.052 ml |
0.258 ml |
0.515 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |